Intl Antiviral Research Organization Allays Concerns Over Availability Of Remdesivir Drug

Simple item page
dc.contributor.authorFH, Sumaira
dc.contributor.authorSeley-Radtke, Katherine
dc.date.accessioned2025-07-30T19:22:56Z
dc.date.issued2020-05-15
dc.description.abstractKatherine Seley-Radtke, a prominent medicinal chemist and the president-elect of the International Society for Antiviral Research (ISAR), dispelled concerns over the possible shortages of Remdesivir, an experimental antiviral drug for treating COVID-19 patients, which many fear takes too long to produce
dc.description.urihttps://www.urdupoint.com/en/world/intl-antiviral-research-organization-allays-921675.html
dc.format.extent2 pages
dc.genrearticles
dc.identifierdoi:10.13016/m2oryk-kjh0
dc.identifier.citationFH, Sumaira and Katherine Seley-Radtke. "Intl Antiviral Research Organization Allays Concerns Over Availability Of Remdesivir Drug". UrduPoint. May 15, 2020. https://www.urdupoint.com/en/world/intl-antiviral-research-organization-allays-921675.html
dc.identifier.urihttp://hdl.handle.net/11603/39628
dc.language.isoen_US
dc.publisherUrduPoint
dc.relation.isAvailableAtThe University of Maryland, Baltimore County (UMBC)
dc.relation.ispartofUMBC Faculty Collection
dc.relation.ispartofUMBC Chemistry & Biochemistry Department
dc.rightsThis item is likely protected under Title 17 of the U.S. Copyright Law. Unless on a Creative Commons license, for uses protected by Copyright Law, contact the copyright holder or the author.
dc.subjectAntiviral
dc.subjectRemdesivir Drug
dc.subjectCOVID-19
dc.titleIntl Antiviral Research Organization Allays Concerns Over Availability Of Remdesivir Drug
dc.typeText
dcterms.creatorhttps://orcid.org/0000-0002-0154-3459

Files

Collections

UMBC Faculty Collection
UMBC Chemistry & Biochemistry Department